Literature DB >> 12097797

Citicoline treatment increases retinal dopamine content in rabbits.

Robert Rejdak1, Jerzy Toczołowski, Janusz Solski, Dariusz Duma, Paweł Grieb.   

Abstract

Citicoline (exogenous cytidine-5'-diphosphocholine) was reported to enhance dopaminergic neurotransmission in the brain. A few clinical studies showed beneficial effects of this drug on the function of the visual pathway in patients with glaucoma or amblyopia. The present study was aimed at determining whether citicoline could influence retinal catecholamine levels in adult male Albino rabbits. The animals received the drug (50 mg/kg i.p., twice daily) or vehicle for 7 days, and retinal catecholamine concentrations were determined by HPLC. Compared to vehicle-treated controls, citicoline-treated animals displayed a significantly higher retinal dopamine concentration and a tendency toward an increase in adrenaline concentration, while the noradrenaline concentration remained unchanged. It is, therefore, conceivable that citicoline reinforces dopaminergic transmission in the retina. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12097797     DOI: 10.1159/000063658

Source DB:  PubMed          Journal:  Ophthalmic Res        ISSN: 0030-3747            Impact factor:   2.892


  22 in total

1.  Citicoline affects appetite and cortico-limbic responses to images of high-calorie foods.

Authors:  William D S Killgore; Amy J Ross; Toshikazu Kamiya; Yoko Kawada; Perry F Renshaw; Deborah A Yurgelun-Todd
Journal:  Int J Eat Disord       Date:  2010-01       Impact factor: 4.861

Review 2.  The treatment of amblyopia: current practice and emerging trends.

Authors:  Eleni Papageorgiou; Ioannis Asproudis; Gail Maconachie; Evangelia E Tsironi; Irene Gottlob
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-01-31       Impact factor: 3.117

Review 3.  Potential neuroprotective biomolecules in ophthalmology.

Authors:  Mehrdad Afarid; Fatemeh Sanie-Jahromi
Journal:  Int Ophthalmol       Date:  2020-11-12       Impact factor: 2.031

4.  Citicoline retards myopia progression following form deprivation in guinea pigs.

Authors:  Junfeng Mao; Shuangzhen Liu; Chunyan Fu
Journal:  Exp Biol Med (Maywood)       Date:  2016-03-14

5.  The citicoline brain injury treatment (COBRIT) trial: design and methods.

Authors:  Ross Zafonte; William T Friedewald; Shing M Lee; Bruce Levin; Ramon Diaz-Arrastia; Beth Ansel; Howard Eisenberg; Shelly D Timmons; Nancy Temkin; Thomas Novack; Joseph Ricker; Randall Merchant; Jack Jallo
Journal:  J Neurotrauma       Date:  2009-12       Impact factor: 5.269

Review 6.  An update on pharmacological treatment options for amblyopia.

Authors:  Aldo Vagge; Lorenzo Ferro Desideri; Carlo Enrico Traverso
Journal:  Int Ophthalmol       Date:  2020-08-07       Impact factor: 2.031

7.  Effect of oral CDP-choline on visual function in young amblyopic patients.

Authors:  Michela Fresina; Anna Dickmann; Annabella Salerni; Fabio De Gregorio; Emilio C Campos
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-07-19       Impact factor: 3.117

Review 8.  Neuroprotective properties of citicoline: facts, doubts and unresolved issues.

Authors:  Pawel Grieb
Journal:  CNS Drugs       Date:  2014-03       Impact factor: 5.749

9.  Effectiveness of the addition of citicoline to patching in the treatment of amblyopia around visual maturity: a randomized controlled trial.

Authors:  Prachee Vasant Pawar; Sachin S Mumbare; Mrunal Suresh Patil; Seema Ramakrishnan
Journal:  Indian J Ophthalmol       Date:  2014-02       Impact factor: 1.848

Review 10.  Citicoline: A Food Beneficial for Patients Suffering from or Threated with Glaucoma.

Authors:  Pawel Grieb; Anselm Jünemann; Marek Rekas; Robert Rejdak
Journal:  Front Aging Neurosci       Date:  2016-04-08       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.